On the one hand, this nanoparticle could target cancer cells through AS1411 aptamer; on the other hand, in the presence of VEGF, the MOF could be unlocked and the DOX was released, thus accurately killing the tumor (Chen et al., 2018d). The gene discussed is VEGFA; the disease is cancer.